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Background: Fibrosis aftermyocardial damage can be determined by cardiacmagnetic resonance (CMR)with late
gadolinium enhancement (LGE). We studied whether ventricular LGE is visible in the ventricles of pediatric and
adolescent TOF (tetralogy of Fallot) patients bymeasuring LGE and investigatingwhetherﬁbrosis correlatedwith
right ventricular volume, pulmonary regurgitation, N-terminal pro-brain natriuretic peptide (NT-proBNP) or the
aminoterminal propeptide of type III procollagen (PIIINP). We also studied if the patient's age, post-operative
follow-up time or surgical history would affect LGE.
Methods: A total of 40 pediatric patients who had undergone TOF repair and 43 healthy age and gender matched
controls underwent a CMR study, whereby LGEwas scored in the right (RV) and the left ventricle. To exclude the
possible iatrogenic scarring we calculated the LGE score by excluding the right ventricular outﬂow tract and VSD
patch region.
Results: All patients had RV LGE and in 39 of 40 it was seen also outside the surgically affected areas. The amount
of LGE correlated positively with the RV end-diastolic volume (r= 0.44, P= 0.0045), pulmonary regurgitation
(r = 0.40, P = 0.013), and with NT-proBNP. The presence of LGE also depended on post-operative follow-
up time (r = 0.53, P = 0.006). PIIINP levels of TOF patients were signiﬁcantly higher than in the control
subjects but it did not correlate with LGE or with any of the studied clinical markers.
Conclusions: LGE is present globally in the right ventricular muscle in children and adolescents with TOF. The
longer the follow-up time the more common was the LGE in the right ventricle.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Congenital heart defect is present in 0.5–1% of newborn infants and
3–5% of the patients are born with tetralogy of Fallot (TOF) [1–4]. The
outcome of these patients has improved dramatically during the last
decades but the long-term prognosis is still compromised by important
chronic sequelae like right ventricular (RV) scarring, dysfunction,
dilation and arrhythmias leading to higher morbidity and mortality
than in their peers [4,5]. Surgical correction of right ventricular outﬂow
tract (RVOT) obstruction often results in pulmonary regurgitation
causing chronic volume loading, and eventually RV dilatation andhis studywas supported by the
ish Cardiac Foundation, and the
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sity of Helsinki Stenbäckinkatu
ax: +358 9 47175306.
land Ltd. This is an open access articldeterioration of its function [6–10]. The pathophysiology behind these
hemodynamic conditions has remained elusive.
Late gadolinium enhancement (LGE) is a method where cardiovas-
cularmagnetic resonance (CMR) images are obtained after the adminis-
tration of gadolinium contrast material that accumulates into a tissue
with increased extra cellular space. This method is suggestive of ﬁbrosis
in both the left and right ventricles [11,12]. In previous studies the im-
portance of RVOT ﬁbrosis detected by MRI LGE has been highlighted
in adult and adolescent series of patients [13,14]. In a patient cohort of
9–67 year old individuals with TOF, regional RV dysfunctionwas associ-
ated with LGE in many segments of myocardium [15]. Another recent
study demonstrated a relation of fragmented QRS complex to RV LGE
[16]. However, little is known about LGE in pediatric TOF patients.
The goal of this study was to establish whether LGE was present in
children and adolescentswith surgically repaired TOF. Our special inter-
est was to study those myocardial segments not directly injured and
scarred by the corrective surgery.We studied if RV end-diastolic volume
(EDV ml/m2), ejection fraction (EF) or pulmonary regurgitation (PR)
measured by CMR would correlate with LGE. We also studied whether
LGE depended on surgical method of repair, post-operative follow-upe under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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plasma N-terminal pro-brain natriuretic peptide (NT-proBNP), a well-
established marker for heart failure [17–19], found elevated with in-
creased RV volume and pulmonary regurgitation in adult and adoles-
cent series of patients [20–22]. Finally, since LGE has previously been
demonstrated in processes with increasing ﬁbrosis [13–15,24] we stud-
ied whether aminoterminal propeptide of the type III procollagen
(PIIINP), a biochemical marker of this ﬁbrillar collagen turnover,
would correlate with right ventricular LGE, its end diastolic volume, or
the extent of the pulmonary regurgitation.
2. Methods
Forty-ﬁve patients who had undergone surgical repair of TOF be-
tween 1990 and 2003 were recruited to the study. 39 patients arrived
from the Helsinki University Hospital district, serving a population
base of 1.7 million. The inclusion criteria were suspicion of a severe pul-
monary regurgitation in echocardiography. Six additional patients ar-
rived from other hospitals referred by their own pediatric cardiologist
according to the same criteria. Three patients declined from the study
and two patients were rejected because of insufﬁcient MRI image qual-
ity. Accordingly, forty patients were admitted to the study andwere ex-
amined during an annual ambulatory visit to the clinic. For control
subjects, 43 healthy age and gender matched pediatric and adolescent
volunteerswere recruited around theHelsinki area. Theywere accepted
to the study if they had nomedical history of any cardiovascular disease
and no other pre-existing condition thatwould affect the cardiovascular
system.No subjects had any other known conditions associatedwith el-
evated levels of plasma concentrations of PIIINP such as pulmonary ﬁ-
brosis, chronic liver disease or renal dysfunction. All of the patients
and control subjects underwent a clinical examination by the pediatric
cardiologist. The study protocol included an echocardiogram, a CMR
study, and a blood sample, from each of the subjects.
The Ethics Committee of the Children's Hospital of the Helsinki Uni-
versity CentralHospital approved the study. Awritten informed consent
was obtained from all the participants and/or their parents.
CMR images were obtained with a 1.5 T Philips Achieva imager
(Philips Healthcare, The Netherlands) and a 5 channel cardiac coil. For
right-ventricular-volume analysis, transaxial and left ventricle (LV)
short axis balanced turbo ﬁeld echo (B TFE) breath-hold cine images
were obtained throughout the whole heart. Slice thickness was
5–8 mm depending on the patient size, gap was 20% and temporal res-
olutionwas 26–43ms. For RV enddiastolic volumemeasurements, both
the transaxial and the LV short axis cine images were manually
planimetered with the cardiac analysis tool of a Philips ViewForum
workstation (Philips Healthcare, The Netherlands). Pulmonary arterial
ﬂow and regurgitation were assessed using a through plane phase con-
trast measurement. The phase contrast plane was positioned perpen-
dicular to the pulmonary artery ﬂow one 1 cm above the valve. A
retrospectively gated free breathing acquisition with three averages
lasting typically for one minute was obtained with a temporal resolu-
tion of 24 ms and VENC 200. The ﬁeld of view was kept as small as
possible for optimal spatial resolution and slice thickness = 10 mm,
TR = 4.019, TE = 2.427, and ET = 4. The ﬂow images were analyzed
with the workstation provided by the MR scanner vendor. A radiologist
experienced in CMR performed all CMR analysis.
For LGE analysis, transaxial and sagittal late enhancement images
were obtained from both ventricles after 10 min of Gd-DOTA,
Gadoterate meglumine 279.3 mg/ml (Dotarem®) 0.2 ml/kg injection.
A gradient echo sequence with TR = 3.239 ms, TE = 1.628 ms and ET
= 49 was used. Slice thickness was 7 mm with no gap. The inversion
time (TI) was determined with the use of TI-scout sequence and varied
between 260 and 360 ms.
RV LGE grading protocol with seven RV segments including the tar-
get cites of repair served as a basis for our grading method [13]. For the
present work we performed scoring of LGE similarly to this earlierprotocol, but adapted the method by omitting 2 surgically manipulated
segments (VSD patch region and the anterior wall of RVOT) to quanti-
tate remote LGE within the RVs. Accordingly, 5 remote segments were
used in the analysis: anterior wall of RV, inferior wall of RV, RV surface
of septum, trabecular bands and RV insertion points. The late enhance-
ment images were visually assessed and each segment was graded ac-
cording to the linear extent of enhanced myocardium. The protocol is
described in detail in Fig. 1. Meticulous care was taken to conﬁrm RV
LGE from different views. The radiologist was blinded to the clinical
status and other ﬁndings of the patients. Typical late enhancement
ﬁndings are shown in Figs. 2 and 3. For the LV LGE scoring, a standard
17-segment model was used [23].
The radiologist blinded to the primary results later repeated scoring
of 23 patients' LGE images. A good correlation (R2 = 0.77) was found
between the two assessments. Bland–Altman method was used to
study intra-observer variability and found a difference in average
score of 0.47. Difference of the individual scores was between−1 and
+1 in 95% of the measurements.
Blood samples from a peripheral vein were drawn from all the sub-
jects into vials with an appropriate anticoagulant agent followed by
plasma separation by centrifugation. NT-proBNP was measured from
the plasma by immunochemiluminometric assay at the biochemical
laboratory immediately after the sample was taken. Another part of the
separated plasma was stored at−70 °C for later analysis, from which
plasma levels of PIIINP were measured using a commercially available
radioimmunological method (Orion Diagnostica UniQ PIIINP RIA, Orion
Corporation Orion Diagnostica, Espoo, Finland). All analyses were
performed in duplicate, and the average was used as a single datum.
The analytic data of the control patients demonstrated that circulating
PIIINP did not change between 7 and 19 years of age. Accordingly, no
age-dependent correction was needed to the analytic data on PIIINP.
Statistical analysis was performed using GraphPad Prism 5.0a
(GraphPad Software, Inc. San Diego, California, USA). All results are re-
ported as a mean ± SD. Comparisons of continuous data between the
groups were performed using an unpaired t test. Correlations were cal-
culated by using linear regression. A two-tailed P-value of less than 0.05
was considered statistically signiﬁcant. Intra-observer variability was
tested by using Spearman's test and Bland–Altman method.3. Results
The average age of our TOF patients was 13.1 ± 3.3 (range 7.7–
18.7 years). The mean post-operative follow-up time of our patients
was 11.8 ± 2.9 years from the corrective surgical procedure (range
7.2–18.4). All patients were of NYHA class I–II and all control patients
were of NYHA class I. A total of 16 (40%) of the patients had undergone
palliative procedure in the early childhood before the corrective
surgery. Transannular patch (TAP) was used in 23 (58%) patients. All
the corrective operations were done on cardiopulmonary bypass with
aortic crossclamp. The myocardium was protected with cold blood
cardioplegia. During the follow-up time a reoperation was done to 6
(15%) of our patients. Table 1.summarizes the baseline characteristics
of TOF patients and healthy controls. Therewere no time-related trends
in surgical techniques and all methods were used constantly during the
operative period from 1990 to 2003.
Visible RV LGE was present in all of our patients when all segments
of RV where studied. Our interest was to explore whether RV LGE could
be seen as remote enhancements outside the surgical scars. Therefore,
we performed also a LGE score calculation by excluding enhanced
areas of the right ventricular outﬂow tract (RVOT) and the ventricular
septal defect (VSD) patch. This remote LGE was found in 39 out of 40
of our patients. Both LV and RV LGEwere absent in the control subjects.
Remote LGE was frequently found in all 5 remote segments of RV.
Most commonly it was found in the anterior wall (33 of 40 patients)
followed by RV insertion points (27/40). In three other segments it
Fig. 1. Five-step segmental late gadoliniumenhancement (LGE) grading protocol: in theﬁrst three segmentsmeasuring right ventricular (RV) freewall and the interventricular septum the
scoringwas done as follows: 0 points= no enhancement, 1 point b 2 cm, 2 points= 2–3 cm and 3 points= N 3 cm in length. RV trabeculationswere scored as 0=no enhancement, 1=
enhancement of one trabeculation, 2= enhancement of 2–4 trabeculations and 3= enhancement of more than 4 trabeculations. RV-left ventricular insertion points were scored either 0
or 1 for absence or presence of enhancements.
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septum in 15 and in the trabecular bands in 9 patients out of 40.
We found a signiﬁcant positive correlation between remote RV LGE
and RV end-diastolic volume (Fig. 4A). The remote LGE scorewas signif-
icantly higher in patients with severe PRwhen compared to thosewith-
out (Fig. 4B). The amount of pulmonary regurgitation also correlated
positively with RV EDV (r = 0.40, P = 0.01).
Since remote LGE was related to pulmonary regurgitation and right
ventricular dilation, we studied if post-operative follow-up time
would affect LGE. In patients with moderate (N20%) or severe (≥30%)
pulmonary regurgitation a linear regression analysis demonstrated
a correlation between postoperative follow-up time and remote LGE
(r= 0.53, P= 0.006, Fig. 4C). Therewas a suggestive negative trendbe-
tween RV EF and LGE score but it did not reach statistical signiﬁcance.
We then studied whether the levels of two circulating biochemical
markers available for diagnostics and follow-up of myocardial disease,
namely the NT-proBNP and PIIINP, would parallel RV ﬁbrosis or RV
size and function. The levels of NT-proBNP were clearly elevated inFig. 2. Transaxial late gadolinium enhancement (LGE) image of a 14-year-old girl with te-
tralogy of Fallot (TOF). The arrows indicate anterior right ventricular (RV) wall enhance-
ments 10 min after gadolinium-injection.our patient group as shown in Table 2. A linear regression analysis dem-
onstrated a correlation between remote LGE score and NT-proBNP
levels (r = 0.38, P = 0.015). In addition, after pooling the data from
the control subjects and patients, signiﬁcant positive correlation existed
between NT-proBNP and RV EDV and a negative correlation between
NT-proBNP and RV EF (Fig. 5A and B).
Comparison between the patients and control subjects demonstrat-
ed that the plasma levels of PIIINP were signiﬁcantly higher in TOF-
patients. However, there was no correlation between PIIINP and CMR-
ﬁndings or other clinical and biochemical data.
4. Discussion
An important ﬁnding of our study was that the RV LGE was present
in children with surgically repaired TOF and these LGE changes were
more abundant in patients as the right ventricle dilation, age, and
follow-up time progressed.
Another new ﬁnding of this study was that RV myocardial LGE was
found in remote areas of RV of these young patients. We propose that
pulmonary regurgitation, signiﬁcantly present in our patients, andFig. 3. Sagittal late gadolinium enhancement (LGE) image of a 15 year old boy with tetral-
ogy of Fallot (TOF). The arrow indicates posterior ventricular junction enhancement
10 min after gadolinium-injection.
Table 1
Characteristics of the study population.
Patients Controls P value
N 40 43
Male gender, n (%) 25 (63) 27 (63) ns.
Mean age (years) 13.1 ± 3.2 14.1 ± 3.4 ns.
Age range (years) 8.2–18.9 7.7–19.3 ns.
Weight (kg) 43.0 ± 14.6 50.9 ± 15.9 ns.
Height (cm) 153 ± 14.9 160 ± 16.0 ns.
Body surface area (m2) 1.3 ± 0.3 1.5 ± 0.3 ns.
Age at TOF repair (years) 1.4 ± 1.2 –
Fig. 4. A correlation between right ventricular end diastolic volume (RV EDV) and remote
late gadolinium enhancement (LGE) score (r= 0.44, P = 0.0045, n= 40). B: remote late
gadolinium enhancement (LGE) score of patients with severe pulmonary regurgitation
(PR) (≥30%) when compared to patients with PR b 30% (P = 0.008, n = 40). C: correla-
tion between post-operative follow-up time and remote late gadolinium enhancement
(LGE) score (r = 0.53, P = 0.006, n = 25). Only patients with ≥20% pulmonary regurgi-
tation were included to this analysis.
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loading physiology seen in tetralogy of Fallot, might be an important
factor in causing these global ﬁndings within the RV-myocardium.
However, since LGE was present even outside the areas surgically ma-
nipulated during RVOT-resection and VSD patching, non-speciﬁc fac-
tors, including the extent of pre-operative cyanosis or perioperative or
post-operative ischemic insults, might have enhanced the pathophysio-
logical mechanism leading to RV LGE and dilation. In addition, myocar-
dial LGEmight also be at least partly a result of fetal programming of the
extra cellular matrix framework, which has previously been described
to differ in RV muscular wall of neonatal patients with hypoplastic left
heart syndrome and truncus arteriosus [24].
LGE has become a marker of ﬁbrotic, scarred or otherwise abnormal
myocardium. It has been previously studied in both ischemic and non-
ischemic heart disease, and CMR LGE has contributed to understanding
LV dysfunction and the pathophysiology behind in these diseases
[12,25–27]. Correlation between LGE and myocardial ﬁbrosis has also
been validated in earlier histological studies [28,29]. In adult patients
with TOF, RV LGE has correlated with adverse clinical markers such as
ventricular dysfunction and arrhythmias [13]. Accordingly, parallel to
these previously published data we suggest that the adverse hemody-
namic loading conditions induced by the post-operative anatomic and
hemodynamic conditions are deleterious to the myocardium. In future
investigations, it would be interesting to study whether, in the chronic
stage of TOF, RV LGE is different in patients with restrictive RV-
physiology with attenuated RV-remodeling [30].
LV LGE was not found in any of our patients. No LV venting was
done in any of the patients during the TOF repair. In adult patients
with TOF, LGE ﬁndings vary: in one study where patients were oper-
ated on during adult life, LV LGE was found in 53% of the patients
[13]. In another study, no signiﬁcant LV LGEwas encountered in a co-
hort of 9–67 year old individuals after repair of TOF [15]. Differences
in surgical era and the surgical approach, including the omittance of
left ventricle venting, could explain these differences. Since our pa-
tients were children and adolescents, it is also possible that LV LGE
develops later in life.
Consistent with previous observations, our present ﬁndings demon-
strated an increased amount of plasma PIIINP in patients with TOF com-
pared to their age-matched control population. However, PIIINP did not
show correlation with LGE, which generally is anticipated to derive at
least for some extent from increased ﬁbrosis within the myocardium.
In light of the recent literature we feel that this is not surprising since
the extracardiac synthesis of ﬁbrillar collagens is signiﬁcant [31]. In ad-
dition, extracardiac turnover of collagens varies not only in noncardiac
diseases but also in cardiac disease associated with abnormal loading
conditions [32]. These observationsmay somewhat decrease attractive-
ness of the circulating collagen-derived peptides as diagnostic and
follow-up tools in clinical cardiology [33].
Our study demonstrated a correlation between NT-proBNP and LGE.
In parallel with previously published studies in somewhat older pa-
tients with TOF [20–22] we found signiﬁcant correlations between
NT-proBNP and RV EDV, pulmonary regurgitation, and RV function.
Thus, our present ﬁndings add weight on the hypothesis that gradualdilation of RV after TOF-repair provokes ﬁbrosis within the myocardi-
um, which can be detected by RV LGE.
5. Conclusion
We conclude that RV LGE is present in children after repair of tetral-
ogy of Fallot and it is found also outside the surgically injured areas. The
amount of LGE correlates with the severity of PR and RV dilation.
Our data on serum NT-proBNP suggests that RV LGE reﬂects right
Table 2
Right and left ventricular size and function, plasma levels of N-terminal pro-brain natri-
uretic peptide (NT-proBNP) and pro-collagen III (PIIINP) of 40 pediatric patients with
tetralogy of Fallot (TOF) and their age-matched controls.
Patients Controls P value
Number of subjects 40 43
RV EDV ml/m2 115 ± 26.5 83.6 ± 14.8 b0.0001
RV EF (%) 50.1 ± 8.6 60.0 ± 4.8 b0.0001
Pulmonary regurgitation (%) 28.5 ± 17.7 0.5 ± 2.50 b0.0001
LV EDV ml/m2 75.3 ± 15.1 80.9 ± 13.7 ns.
LV EF (%) 61.6 ± 8.6 63.0 ± 4.8 ns.
Aortic regurgitation (%) 1.3 ± 2.9 0
NT-proBNP levels (ng/l) 147 ± 82 53 ± 36 b0.0001
Plasma PIIINP levels (μg/l) 12.3 ± 4.9 9.1 ± 3.9 0.0009
19P. Ylitalo et al. / IJC Heart & Vessels 3 (2014) 15–20ventricular dilation. We propose that the study of LGE might provide
valuable additional information in decision-making for the timing of
the operative treatment.
6. Study limitations
Our studywas cross-sectional, and a longer follow-upwith repeated
clinical, radiological and biochemical assessments would be needed to
conﬁrm whether the right ventricle ﬁbrosis in children after TOF repair
is progressive. Only one marker of ﬁbrous collagen turnover was used.Fig. 5. A correlation between N-terminal pro-brain natriuretic peptide (NT-proBNP) and
right ventricular end diastolic volume (r = 0.54, P b 0.0001, n = 83). B: correlation
between N-terminal pro-brain natriuretic peptide (NT-proBNP) and right ventricular
ejection fraction (r =−0.41, P = 0.0002, n = 83).However, inclusion of type I collagen derived PICP and PINP was not
considered due to the potential confounding factors due to the ubiqui-
tous content of type I collagen within the parenchymal organs, skin
and the skeleton.Acknowledgments
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